Upstream Bio, Inc. (UPB) earnings
Quarterly results of Upstream Bio, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Upstream Bio, Inc. was expected to report around November 4, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Upstream Bio, Inc. reported revenue of $773K (-17.5% on the same quarter a year earlier) and a net loss of $39.7M.
Diluted earnings per share were -$0.73.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $773K | -17.5% | -$39.7M | -$0.73 |
| Q1 FY2026 | $1M | +82.7% | -$40.6M | -$0.75 |
| Q4 FY2025 | $668K | +9% | -$42.5M | - |
| Q3 FY2025 | $683K | +12.5% | -$33.7M | -$0.63 |
| Q2 FY2025 | $937K | - | -$40M | -$0.74 |
| Q1 FY2025 | $566K | - | -$27.3M | -$0.51 |
| Q4 FY2024 | $613K | - | -$21.2M | - |
| Q3 FY2024 | $607K | - | -$16M | -$6.96 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Annual report 10-K
- Quarterly results 8-K
- Quarterly results 8-K
When is Upstream Bio, Inc.'s next earnings date?
Upstream Bio, Inc. was expected to report around November 4, 2026; nothing is on file with the SEC yet.
What were Upstream Bio, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Upstream Bio, Inc. reported revenue of $773K and a net loss of $39.7M. The figures come from its filing with the SEC.
Is Upstream Bio, Inc.'s revenue growing?
Revenue in Q2 FY2026 was $773K, down 17.5% from $937K in the same quarter a year earlier.
Get an email when UPB reports
Follow UPB and we email you its next results the day they are filed, with the numbers explained.